We are live on
!
Find out more
SCM
Silvant Capital Management Portfolio holdings
AUM
$2.89B
1-Year Est. Return
34.45%
This Fund
S&P 500
This Quarter
Est. Return
+11.79%
1 Year Est. Return
+34.45%
3 Year Est. Return
+148.47%
5 Year Est. Return
+205.7%
10 Year Est. Return
–
AUM
$534M
AUM Growth
-$21.9M
(-3.9%)
Cap. Flow
-$79.4M
Cap. Flow
% of AUM
-14.86%
Top 10 Holdings %
Top 10 Hldgs %
43.67%
Holding
341
New
6
Increased
22
Reduced
97
Closed
12
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Akamai
AKAM
|
+$1M |
| 2 |
Teladoc Health
TDOC
|
+$518K |
| 3 |
CCXI
ChemoCentryx, Inc.
CCXI
|
+$307K |
| 4 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$200K |
| 5 |
EGIO
Edgio, Inc. Common Stock
EGIO
|
+$179K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$8.63M |
| 2 |
Microsoft
MSFT
|
+$8.52M |
| 3 |
Amazon
AMZN
|
+$7.33M |
| 4 |
Visa
V
|
+$3.3M |
| 5 |
Meta Platforms (Facebook)
META
|
+$3.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32% |
| 2 | Consumer Discretionary | 14.6% |
| 3 | Healthcare | 14.58% |
| 4 | Financials | 11.75% |
| 5 | Communication Services | 11.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Apple
AAPL
$4.8T
| $53.9M | 10.09% |
465,684
-79,100
| -15% | -$8.63M |
|
|
2
Microsoft
MSFT
$2.99T
| $48.3M | 9.05% |
229,807
-40,570
| -15% | -$8.52M |
|
|
3
Amazon
AMZN
$2.69T
| $37.3M | 6.98% |
236,760
-46,520
| -16% | -$7.33M |
|
|
4
Visa
V
$686B
| $17.4M | 3.25% |
86,963
-16,505
| -16% | -$3.3M |
|
|
5
Meta Platforms (Facebook)
META
$1.64T
| $16M | 2.99% |
60,919
-12,648
| -17% | -$3.26M |
|
6
Mastercard
MA
$484B
| $14.7M | 2.75% |
43,437
-5,856
| -12% | -$1.9M |
|
7
Alphabet (Google) Class A
GOOGL
$4.3T
| $13.5M | 2.53% |
184,280
-32,200
| -15% | -$2.45M |
|
|
8
Alphabet (Google) Class C
GOOG
$4.29T
| $12.4M | 2.33% |
169,440
-33,260
| -16% | -$2.54M |
|
9
Home Depot
HD
$332B
| $10.3M | 1.92% |
37,021
-5,000
| -12% | -$1.35M |
|
10
Thermo Fisher Scientific
TMO
$196B
| $9.54M | 1.78% |
21,589
-1,484
| -6% | -$613K |
|
11
Costco
COST
$415B
| $9.31M | 1.74% |
26,219
-4,569
| -15% | -$1.54M |
|
12
NVIDIA
NVDA
$4.92T
| $8.66M | 1.62% |
639,920
-171,200
| -21% | -$1.99M |
|
13
TJX Companies
TJX
$172B
| $7.07M | 1.32% |
126,998
-20,934
| -14% | -$1.13M |
|
14
UnitedHealth
UNH
$383B
| $6.55M | 1.23% |
21,011
-5,359
| -20% | -$1.65M |
|
15
Roper Technologies
ROP
$36.6B
| $6.1M | 1.14% |
15,428
-1,199
| -7% | -$499K |
|
16
Netflix
NFLX
$285B
| $6.05M | 1.13% |
120,910
-31,750
| -21% | -$1.58M |
|
17
Autodesk
ADSK
$46B
| $5.91M | 1.11% |
25,583
-6,772
| -21% | -$1.61M |
|
18
Salesforce
CRM
$142B
| $5.7M | 1.07% |
22,690
-5,660
| -20% | -$1.24M |
|
19
DexCom
DXCM
$29.2B
| $5.68M | 1.06% |
55,088
-9,440
| -15% | -$986K |
|
20
S&P Global
SPGI
$133B
| $5.38M | 1.01% |
14,912
-267
| -2% | -$94.2K |
|
21
Walt Disney
DIS
$167B
| $5.19M | 0.97% |
41,820
-3,435
| -8% | -$429K |
|
22
Walmart Inc
WMT
$893B
| $5.17M | 0.97% |
110,949
-1,869
| -2% | -$83.1K |
|
23
O'Reilly Automotive
ORLY
$70.1B
| $4.45M | 0.83% |
144,825
-39,405
| -21% | -$1.2M |
|
24
Edwards Lifesciences
EW
$48.9B
| $4.42M | 0.83% |
55,396
-14,421
| -21% | -$1.13M |
|
25
Honeywell
HON
$71.7B
| $4.32M | 0.81% |
27,830
-2,894
| -9% | -$430K |
|
Similar funds
ZF
AG
NRCM
CWM
BAM
PFM
DMIC
LIP
Silvant Capital Management's Q3 2020 Portfolio in Review
As of Q3 2020, Silvant Capital Management held 341 positions worth $534M, down 3.9% from $556M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Silvant Capital Management withdrew a net $79.4M in Q3 2020, closing 12 positions and reducing 97 holdings. Its most notable exit was HealthEquity, an estimated $390K position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Silvant Capital Management opened a new position in Akamai worth $998K.
- Silvant Capital Management's largest Q3 2020 buy was Akamai: 9,024 shares worth $998K.
- Silvant Capital Management added most to Teladoc Health in Q3 2020, an estimated $518K increase.
- Silvant Capital Management's biggest Q3 2020 reduction was Apple, cutting an estimated $8.63M.
- Silvant Capital Management fully exited HealthEquity in Q3 2020, selling an estimated $390K.
- Silvant Capital Management's ten largest holdings make up 44% of its $534M portfolio in Q3 2020.
- Silvant Capital Management opened 6 new positions and closed 12 in Q3 2020.
- Silvant Capital Management's portfolio value fell 3.9% quarter-over-quarter to $534M.
Based on Silvant Capital Management's 13F filing for Q3 2020, filed 9 Nov 2020.